Key Takeaways
- • Herbalife agreed to pay $20 million to the SEC to settle claims it misled investors for six years about its China business practices, neither admitting nor denying wrongdoing.
- • William Ackman's multi-billion dollar short bet on Herbalife's collapse ended in failure over a year before this settlement; his Pershing Square Capital Management had wagered as much as $1 billion on the company's demise based on pyramid scheme allegations.
- • This marks the second major regulatory penalty in four years: the 2016 FTC settlement required $200 million in payments and an external monitor, but critically allowed Herbalife to continue operations—denying Ackman the "regulatory death knell" he had pursued since his 2012 campaign.
- • The SEC settlement specifically targeted false public statements about service provider compensation in China, where Ackman's 2014 presentation had alleged the company violated China's direct-selling and pyramid-sales laws.
- • Herbalife's regulatory survival despite repeated penalties demonstrates the limits of activist short campaigns against well-capitalized companies with substantial institutional investor backing.
Summary
Herbalife Nutrition reached a $20 million settlement with the Securities and Exchange Commission on September 27, 2019, resolving charges that the company made false and misleading public statements about its China business operations for a six-year period. The settlement order found that Herbalife's statements concerning service provider compensation were deceptive and deprived investors of material information, though the company neither admitted nor denied the allegations as part of the settlement framework.
The timing of this regulatory action underscores the failure of one of Wall Street's most prominent activist short campaigns. William A. Ackman, founder of Pershing Square Capital Management, had waged an intensive battle against Herbalife beginning in 2012, betting as much as $1 billion that the company's stock would collapse. Ackman's central thesis rested on characterizing Herbalife as an unsustainable pyramid scheme, buttressed by a detailed three-hour presentation titled "Who Wants to Be a Millionaire?" and supplemented by critical reports. A 2014 Pershing Square presentation specifically alleged that "Herbalife violates China's directing-selling and pyramid-sales laws." However, Ackman capitulated and unwound his position more than a year before the SEC settlement materialized, effectively exiting the trade at a significant loss.
This settlement represents the second major regulatory enforcement action against Herbalife in three years. In 2016, the Federal Trade Commission imposed a $200 million penalty and required the company to hire an external monitor and implement substantial operational changes. Critically, the FTC allowed Herbalife to continue operations, avoiding the kind of regulatory cessation that Ackman had explicitly targeted. The SEC's more recent $20 million penalty follows the same pattern: enforcement without existential consequence. Despite repeated regulatory findings of misconduct, Herbalife remained a viable, publicly traded enterprise with substantial institutional investor holdings, including positions held by Renaissance Technologies, BlackRock, Fidelity, and State Street.
The gap between Ackman's ambitious short thesis and regulatory outcomes illustrates a fundamental challenge for activist investors: regulatory enforcement, however validating of underlying allegations, may arrive too late to benefit the original campaigner and often falls short of the operational or financial destruction that short positions require for profitability.
The timing of this regulatory action underscores the failure of one of Wall Street's most prominent activist short campaigns. William A. Ackman, founder of Pershing Square Capital Management, had waged an intensive battle against Herbalife beginning in 2012, betting as much as $1 billion that the company's stock would collapse. Ackman's central thesis rested on characterizing Herbalife as an unsustainable pyramid scheme, buttressed by a detailed three-hour presentation titled "Who Wants to Be a Millionaire?" and supplemented by critical reports. A 2014 Pershing Square presentation specifically alleged that "Herbalife violates China's directing-selling and pyramid-sales laws." However, Ackman capitulated and unwound his position more than a year before the SEC settlement materialized, effectively exiting the trade at a significant loss.
This settlement represents the second major regulatory enforcement action against Herbalife in three years. In 2016, the Federal Trade Commission imposed a $200 million penalty and required the company to hire an external monitor and implement substantial operational changes. Critically, the FTC allowed Herbalife to continue operations, avoiding the kind of regulatory cessation that Ackman had explicitly targeted. The SEC's more recent $20 million penalty follows the same pattern: enforcement without existential consequence. Despite repeated regulatory findings of misconduct, Herbalife remained a viable, publicly traded enterprise with substantial institutional investor holdings, including positions held by Renaissance Technologies, BlackRock, Fidelity, and State Street.
The gap between Ackman's ambitious short thesis and regulatory outcomes illustrates a fundamental challenge for activist investors: regulatory enforcement, however validating of underlying allegations, may arrive too late to benefit the original campaigner and often falls short of the operational or financial destruction that short positions require for profitability.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.